These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28765885)

  • 1. Anti-angiogenic properties of artemisinin derivatives (Review).
    Wei T; Liu J
    Int J Mol Med; 2017 Oct; 40(4):972-978. PubMed ID: 28765885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway.
    Banskota S; Gautam J; Regmi SC; Gurung P; Park MH; Kim SJ; Nam TG; Jeong BS; Kim JA
    PLoS One; 2016; 11(1):e0148133. PubMed ID: 26824764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
    Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
    Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the PI3K/Akt/mTOR pathway in ocular neovascularization.
    Sasore T; Reynolds AL; Kennedy BN
    Adv Exp Med Biol; 2014; 801():805-11. PubMed ID: 24664774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMPP is a novel VEGFR2 inhibitor that suppresses angiogenesis via VEGFR2/AKT/ERK/NF-κB pathway.
    Kim NY; Park HM; Park JY; Kim U; Shin HY; Lee HP; Hong JT; Yoon DY
    BMB Rep; 2024 May; 57(5):244-249. PubMed ID: 37964635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.
    Yue GG; Lee JK; Kwok HF; Cheng L; Wong EC; Jiang L; Yu H; Leung HW; Wong YL; Leung PC; Fung KP; Lau CB
    Sci Rep; 2015 Jun; 5():11149. PubMed ID: 26053458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
    Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
    Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling.
    Lu X; Blatt S; Dawood M; Klauck SM; Fleischer E; Kämmerer PW; Efferth T
    Eur J Pharmacol; 2022 Sep; 930():175158. PubMed ID: 35878807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells.
    Lee TH; Jung H; Park KH; Bang MH; Baek NI; Kim J
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1325-34. PubMed ID: 24939823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling.
    Zhao K; Song X; Huang Y; Yao J; Zhou M; Li Z; You Q; Guo Q; Lu N
    Eur J Pharmacol; 2014 Aug; 737():57-69. PubMed ID: 24858369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gedunin abrogates aldose reductase, PI3K/Akt/mToR, and NF-κB signaling pathways to inhibit angiogenesis in a hamster model of oral carcinogenesis.
    Kishore T KK; Ganugula R; Gade DR; Reddy GB; Nagini S
    Tumour Biol; 2016 Feb; 37(2):2083-93. PubMed ID: 26342697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis.
    Yang GW; Jiang JS; Lu WQ
    Int J Mol Sci; 2015 Oct; 16(10):24011-31. PubMed ID: 26473837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2.
    Rho SB; Song YJ; Lim MC; Lee SH; Kim BR; Park SY
    Cell Signal; 2012 Jan; 24(1):131-9. PubMed ID: 21893193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gleditsioside B, a triterpene saponin isolated from the anomalous fruits of Gleditsia sinensis Lam., abrogates bFGF-induced endothelial cell migration through preventing the activation of MMP-2 and FAK via inhibiting ERK and PI3K/AKT signaling pathways.
    Tong B; Lu D; Wei Z; Wang T; Xia Y; Dai Y
    Vascul Pharmacol; 2013 Jan; 58(1-2):118-26. PubMed ID: 23026290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases.
    Efferth T; Oesch F
    Med Res Rev; 2021 Nov; 41(6):3023-3061. PubMed ID: 34288018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.